期刊
CLINICAL KIDNEY JOURNAL
卷 7, 期 1, 页码 11-22出版社
OXFORD UNIV PRESS
DOI: 10.1093/ckj/sft135
关键词
anti-angiogenesis drugs and cancer; anti-cancer drugs and nephrotoxicity; androgen deprivation therapy and AKI
Cancer patients may develop a variety of kidney lesions that impair not only their immediate survival but also limit the adequate treatment of the underlying malignant process. This review summarizes the nephrotoxic potential of some of the most recently developed anti-cancer drugs, focusing on those interfering with the vascular endothelial growth factor and epidermal growth factor receptor pathways and mammalian target of rapamycin inhibitors. Thrombotic microangiopathy (haemolytic-uraemic syndrome), proteinuria, hypertension and magnesium depletion are the most common side effects. Also the risk for developing acute kidney injury in patients with advanced prostate cancer undergoing androgen deprivation therapy is discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据